Skip to main content
PBLS logo

PBLS · Parabilis Medicines, Inc. · Executive Compensation

Track PBLS — free
$29.79 +0.54 (+1.85%)
Market Cap
$3.70B
Shares
123.53M
Volume · Nov 4 501.62K Avg daily vol (3M) 887.95K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Craig Tendler Appointed 2026-08-25

Leadership

Key facts CIK 1657677 CUSIP 698955101 13F (30d) 17 filings 17 filers Visit website Investor relations